Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
Jun 2, 2025 2:31 PM
(Reuters) -Merck ( MRK ) has held talks to buy Swiss biotech MoonLake Immunotherapeutics ( MLTX ) for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.